Search
RPI-MN
go.drugbank.com/drugs/DB17957Experimental[A260132] Being developed by Nutra Pharma under the trade name PEPTERON, it is being investigated for the treatment of neurological and immune disorders.[L47107]
Interferon Gamma
go.drugbank.com/drugs/DB15753InvestigationalThe interferon is primarily produced by activated T lymphocytes and natural killer cells.
Nurulimab
go.drugbank.com/drugs/DB18946InvestigationalNurulimab is under investigation in clinical trial NCT05732805 (A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-pd-1 Compared to Anti-pd-1 Monotherapy as First-line Treatment in
Amiloxate
go.drugbank.com/drugs/DB11207ApprovedAmiloxate is an EMA-approved chemical UV-filter found in over-the-counter sunscreen products at concentrations up to 10%m . It is often referred to as isoamyl 4-methoxycinnamate or isoamyl p-methoxycinnamate. Amiloxate is a cinnamic acid...
RGX-111
go.drugbank.com/drugs/DB17632InvestigationalDeveloped by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46666]
Sedecamycin
go.drugbank.com/drugs/DB21342ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Sedecamycin is a antibiotic, produced by Streptomyces strain. Sedecamycin has a monoisotopic molecular weight of 501.24 Da.
Streptonigrin
go.drugbank.com/drugs/DB19689ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Streptonigrin is a antibiotic, produced by Streptomyces strain. Streptonigrin has a monoisotopic molecular weight of 506.14 Da.
Synonyms: Antibiotic produced by streptomyces flocculusBicozamycin
go.drugbank.com/drugs/DB20821ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Bicozamycin is a antibiotic, produced by Streptomyces strain. Bicozamycin has a monoisotopic molecular weight of 302.11 Da.
Nilotinib
go.drugbank.com/drugs/DB04868ApprovedInvestigationalNilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). A Phase I clinical trial in 2006 showed that this drug was relatively safe and offered si...
Antithrombin Alfa
go.drugbank.com/drugs/DB11166ApprovedAntithrombin Alfa is a recombinant antithrombin , an anticoagulant, that is used for the prevention of thromboembolic events in patients that have hereditary deficiency of antithrombin in high risk situations.